A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study.
暂无分享,去创建一个
A. Godwin | A. Sood | H. Lankes | R. Mannel | R. Alpaugh | S. Modesitt | R. Schilder | A. Bonebrake | M. Sill | P. Hanjani | M. Gold | W. Hu